Fundraising Fox

Alleviant Medical Inc

Austin, US · Founded 2017 · Delaware corporation · 5 known investors

alleviantmedical.com ↗

Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).

BiotechHealthtechMedical Devicesin /alleviant-medical@alleviant

Founders & leadership

AB
Adam BermanExecutive Officer, Director
JK
Jacob KriegelExecutive Officer, Director
AP
Avni PatelExecutive Officer, Director
CA
Christopher Alex ArevalosExecutive Officer, Director
AG
Albertien GreijdanusExecutive Officer, Director
GP
Geoff PardoDirector
BR
Brian R SmithDirector
MB
Maria BerkmanDirector
KN
Kirk NielsenDirector
CK
Christopher KasterDirector
JS
Jay SchmelterDirector
IM
Ian MeredithDirector

Investors · 5

Broadview VenturesBoston
RiverVest Venture PartnersSt. Louis · $500K – $3Mvia Jay W. Schmelter · board
TMC Venture FundHouston
Cadence Healthcare VenturesreportedHayward
Vensana Capitalreported · 2 sourcesMinneapolisvia Kirk Nielsen · board

Reported raises · per SEC filings

Form D private placements
▶$90.8MraisedJan 2025 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoff PardoDirector
  • Ian MeredithDirector
  • Brian R SmithDirector
  • Maria BerkmanDirector
  • Adam BermanExecutive Officer, Director
  • Kirk NielsenDirector
  • Christopher KasterDirector
  • Jay SchmelterDirector
Offering amount
$91.4M
Amount sold
$90.8M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$43.9MraisedFeb 2023 · 35 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian R SmithDirector
  • Gowda AshokDirector
  • Kirk NielsonDirector
  • Christopher KasterDirector
  • Maria BerkmanDirector
  • Jay SchmelterDirector
  • Adam BermanExecutive Officer, Director
Offering amount
$88.3M
Amount sold
$43.9M
First sale
Jan 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13MraisedNov 2020 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mary ByronDirector
  • Ashok GowdaDirector
  • Christopher KasterDirector
  • Kirk NielsenDirector
  • Adam BermanExecutive Officer, Director
  • Jacob KriegelDirector
  • Maria BerkmanDirector
Offering amount
$20M
Amount sold
$13M
First sale
May 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMar 2018 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jacob KriegelExecutive Officer, Director
  • Avni PatelExecutive Officer, Director
  • Christopher Alex ArevalosExecutive Officer, Director
  • Albertien GreijdanusExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.1M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.